We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies. Close

The EU Biotech Directive – legislation for disharmony?

Pharmaceutical Law Insight

The EU Biotech Directive – legislation for disharmony?

Nina White of Boult Wade Tennant discusses major divergences in practice in gene and stem cell patenting.

Seven years have passed since Directive 98/44/EC of the European Parliament and of the Council on the Legal Protection of Biotechnological Inventions (the Biotech Directive) came into force. The Directive was introduced to harmonise the laws of the EU with regard to what is and is not patentable in the biotechnology field. As will be seen, seven years on we are perhaps further than ever from the intended goal of harmonisation.

The rest of this document is only available to i-law.com online subscribers.

If you are already a subscriber, please enter your details below to log in.

Enter your email address to log in as a user on your corporate account.
Remember me on this computer

Not yet an i-law subscriber?


Request a trial Find out more